Summary
Formalin-fixed paraffin sections of 55 consecutive bilateral vestibular schwannomas in 46 patients with neurofibromatosis 2 (NF2), and 50 patients with unilateral vestibular schwannomas were investigated immunohistochemically with the monoclonal antibody MIB 1 directed against recombinant parts of Ki-67 antigen.
The immunohistochemical staining was carried out on dewaxed microwave oven-processed paraffin sections of formalin-fixed tumour tissues. The labelling index (LI) obtained was compared to clinical and histological findings in both groups.
There was no correlation between the LI and age of the patients, tumour size, or histological type of tumour (Antoni A or B). Vestibular schwannomas in NF2 showed higher LI than unilateral vestibular schwannomas: the maximal LI found per section (LI max) ranged from 0.4 to 17.6% (mean, 2.7%) in NF2 schwannomas, and from 0 to 9% (mean, 2.2%) in unilateral schwannomas.
These differences may express immunohistochemically some clinical and morphological differences between bilateral and unilateral vestibular schwannomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aguiar PH, Tatagiba M, Dankoweit-Timpe E,et al (1995) Proliferative activity of acoustic neurilemmomas determined by monoclonal antibody MIB 1. Acta Neurochir (Wien) 134: 35–39
Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10: 611–617
Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave processed formalin fixed paraffin sections. Am J Pathol 168: 357–363
Gerdes J, Lemke H, Baisch H, Wacher HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715
Hoshino T, Nagashima T, Cho KG, Murovic JA, Hodes JE, Wilson CB, Edwards MSB, Pitts LH (1986) S-phase fraction of human brain tumours in situ measured by uptake of bromodeoxyuridine. Int J Cancer 48: 369–374
Lesser THJ, Janzer RC, Kleihues P, Fisch U (1991) Clinical growth rate of acoustic schwannomas. Correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1: 11–15
Mapstone TB (1992) Neurofibromatosis and central nervous system tumours in childhood. In: Winn HR, Mayberg MR (eds) Neurosurgery clinics of North America. Saunders, London, pp 771–779
Martin C, Prades JM, Chelikh L (1991) Growth rate of acoustic neuromas. In: Tos M, Thomsen J (eds) Acoustic neuroma. Kluger, Amsterdam, pp 177–182
Mautner VF, Tatagiba M, Guthoff G, Samii M, Pulst SM (1993) Neurofibromatosis 2 in the pediatric age group. Neurosurgery 33: 92–96
National Institutes of Health Concensus Development Conference: neurofibromatosis. Conference statement (1988) Arch Neurol 45: 575–578
Nedzelski JM, Schessel DA, Pfleider A, Kassel EE, Rowed DW (1991) The natural history of growth of acoustic neuromas and its role in non operative treatment. In: Tos M, Thomsen J (eds) Acoustic neuroma. Kluger, Amsterdam, pp 149–158
Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K (1989) Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labelling indices in human brain tumours. J Neurosurg 70: 379–384
Ojemann RG, Martuza RL (1990) Acoustic neuroma. In: Youmans JR (eds) Neurological surgery, 3rd Ed. Saunders, London, pp 3316–3350
Pasquier B, Wozniak ZM, Mouret P, Gratacap B, Charachon R (1991) Evaluation of the acoustic neuroma growth rate by immunohistological techniques. In: Tos M, Thomsen J (eds) Acoustic neuroma. Kluger, Amsterdam, pp 173–176
Reifenberger G, Deckert M, Wechsler W (1989) Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumours. Acta Neuropathol 78: 166–175
Russell G, Rubinstein LJ (1989) Pathology of tumours of the nervous system. Williams and Wilkins, Baltimore, pp 533–560
Samii M, Tatagiba M, Mathies C (1992) Acoustic neurinoma in the elderly: factors predictive of postoperative outcome. Neurosurgery 31: 615–620
Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T (1993) Proliferative potential of brain tumours. Analyses with Ki-67 anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labelling, and nuceolar organizer region counts. Cancer 71: 199–206
Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741–748
Sobel RA (1993) Vestibular (acoustic) schwannomas: histological features in neurofibromatosis 2 and in unilateral cases. J Neuropathol Exp Neurol 52: 106–113
Sterkers O, Eldine MB, Martin N, Viala P, Sterkers JM (1992) Slow versus rapid growing acoustic neuromas. In: Tos M, Thomsen J (eds) Acoustic neuroma. Kluger, Amsterdam, pp 145–147
Tsanaclis AM, Robert F, Michaud J, Brem S (1991) The cycling pool of cells within human brain tumours: in situ cytokinetic using the monoclonal antibody Ki-67. Can J Neurol Sci 18: 12–17
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aguiar, P.H., Tatagiba, M., Samii, M. et al. The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB 1. Acta neurochir 134, 40–45 (1995). https://doi.org/10.1007/BF01428500
Issue Date:
DOI: https://doi.org/10.1007/BF01428500